“…In recent years, several novel biomarkers for AKI have been evaluated in aortic surgery. The most studied biomarkers, derived from urine or plasma samples, are related to cell cycle arrest, such as NGAL, liver-type fatty acid-binding protein (L-FABP), IGFBP-7, TIMP-2, and cystatin C [ 7 , 8 , 9 , 10 , 11 , 29 , 30 , 31 , 32 ]. A few studies have evaluated the predictive ability of blood immune-inflammatory biomarkers such as plasma secretory leukocyte peptidase inhibitor (SLPI), pentraxin 3 (PTX3), IL1-RA, MCP-1, suppressor of tumorigenicity 2 (ST-2), IL-6, and IL-10 [ 19 , 20 , 33 , 34 ].…”